Last updated: February 22, 2016
Sponsor: Immune Response BioPharma, Inc.
Overall Status: Trial Status Unknown
Phase
3
Condition
Hiv
Treatment
N/AClinical Study ID
NCT02366026
IR103-007
Ages > 16 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Are HIV-positive and started anti-HIV drugs soon after tests showed the presence ofHIV.
Are at least 16 years old (consent of parent or guardian required if under 18 years).
Exclusion
Exclusion Criteria:
Healthy Subjects
Currently abuse alcohol or drugs.
Study Design
Total Participants: 500
Study Start date:
June 01, 2017
Estimated Completion Date:
June 30, 2019
Study Description
Connect with a study center
Clinical Site TBA
San Diego, California 92101
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.